Biotie’s BTT1023 in primary sclerosing cholangitis

• Business
• Finland
• Healthcare
• Pharma & Biotech
• Technology

Biotie Therapies Corp: Clinical study with Biotie’s BTT1023 in primary sclerosing cholangitis awarded external grant funding

Turku, Finland, 25-7-2014 — /EuropaWire/ — Biotie Therapies Corp. will be working in partnership with the University of Birmingham, UK, who have…